One Zyme
AI agents for Pharma Business Development and Competitive Intelligence
One Zyme develops artificial-intelligenceādriven tools to help pharma companies design and optimize enzymes for industrial applications. By combining machine learning with biochemical expertise, the company helps industrial players accelerate R&D cycles, improve yields, and reduce the environmental footprint of chemical and biological processes.
The platform focuses on making enzyme engineering faster and more predictable, addressing a key bottleneck in sectors such as specialty chemicals, materials, and biomanufacturing, where traditional trial-and-error approaches remain costly and time-consuming.
Investor: Henri Deshays
